πŸ‡ΊπŸ‡Έ FDA
Patent

US 12187694

SLC26A3 inhibitors and use thereof

granted A61KA61K2300/00A61K31/37

Quick answer

US patent 12187694 (SLC26A3 inhibitors and use thereof) held by The Regents of the University of California expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2300/00, A61K31/37, A61K31/4164, A61K31/472